SteadyMed reports second quarter 2017 financial results
SteadyMed reported a net loss of $8.1 million, or $0.33 per share, compared to a net loss of $7.2 million, or $0.53 per share for the second quarter of 2016. SteadyMed recorded licensing revenues of $319 thousand in the second quarter of 2017, compared to $94 thousand in the second quarter of 2016. August 11, 2017